Controlling Extreme Inflammation in Severe Cases of COVID-19 May Help Save Lives
Immunologists at the Icahn School of Medicine at Mount Sinai are playing a major role in managing the care of severely ill patients with COVID-19, who often experience an excessive inflammatory response to the disease that can ultimately overwhelm...
What Should Gastroenterologists and Patients Know About COVID-19?
Physicians need to consider that gastrointestinal (GI) symptoms, such as nausea, vomiting, and diarrhea could be early signs of COVID-19 infection, especially in those GI patients who also present with upper respiratory complaints. Meanwhile, patients with...
Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients
The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that...
Patients With COVID-19 Have Distinct Markings in Their Lungs, New Study Finds
Patients in China with COVID-19 showed distinct patterns in their lungs that became more defined within a few of days of disease onset, according to two cardiothoracic radiologists at the Mount Sinai Health System, who were the first in the nation to...
Team Identifies Path to Blood Test for Artery Disorder
A Mount Sinai team has gained valuable insights into fibromuscular dysplasia (FMD), a disorder of the arteries that is typically diagnosed in otherwise healthy women at midlife and sometimes causes aneurysms or serious heart disease. The findings could open the door...
Air Pollution and Pregnancy
The higher a mother’s exposure to particulate air pollution during pregnancy, the lower her baby’s heart variability will be in response to stress at 6 months of age. That was the novel conclusion of a study published in the October issue of Environmental Health...
Examining the Effects of Immunotherapy on Cancer
Using a collection of sophisticated single-cell technologies, scientists at the Mount Sinai Health System have launched an early-stage clinical trial that examines the effects of immunotherapy on hepatocellular carcinoma, non-small-cell lung...
Advancing the Study of Brain and Memory
Denise Cai, PhD, Assistant Professor of Neuroscience, Icahn School of Medicine at Mount Sinai, is the recipient of a 2019 National Institutes of Health New Innovator Award to continue her novel research into the brain and memory. The Award was...
A Thank You to Clinical Trial Participants
Physician-scientists from Mount Sinai Beth Israel and The Michael J. Fox Foundation highlighted new treatments and research in Parkinson’s disease during a “Thankfest” symposium and lunch in October. The event was held to recognize the valuable contributions of 60...